Loading organizations...
Loading organizations...
Medical technology company based in China
AccuPulse has raised $59.7M across 4 funding rounds.
AccuPulse has raised $59.7M in total across 4 funding rounds.
AccuPulse has raised $59.7M in total across 4 funding rounds.
AccuPulse's investors include Deng Jianxin, Shanghai Biopharmaceutical Fund, Shengshi Investment Management, Shenzhen Qianhai Capital, Blue Bay Ventures.
AccuPulse has raised $59.7M across 4 funding rounds. Most recently, it raised $6.9M Other Equity in June 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 17, 2024 | $6.9M Other Equity | Deng Jianxin | |
| Feb 7, 2024 | $27.8M Series A | Shanghai Biopharmaceutical Fund, Shengshi Investment Management | |
| May 27, 2022 | $10.0M Series A | Shenzhen Qianhai Capital | Shanghai Biopharmaceutical Fund |
| $15.0M AccuPulse Other Equity 2026 | Blue Bay Ventures, Deng Jianxin |